Search Zepbound (type in keywords)
Search Medical Information
If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Zepbound ® (tirzepatide) injection
2.5 mg/ 5 mg/ 7.5 mg/ 10 mg/ 12.5 mg/ 15 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
What information does Lilly have for a patient who injects Zepbound® tirzepatide in the wrong location?
Tirzepatide should be injected subcutaneously in the abdomen, thigh, or upper arm.
See important safety information, including boxed warning, in the attached prescribing information.
Eli Lilly and Company has no clinical information regarding injecting the medication in other locations.
Enclosed Prescribing Information
Date of Last Review: December 19, 2024
Are you satisfied with this content?